Kala Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350
Kala Pharmaceuticals, Inc.
2024
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Kala Pharmaceuticals, Inc.
2024
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2023
Open Market Sale AgreementSM, dated as of January 19, 2023, by and between Kala Pharmaceuticals, Inc. and Jefferies LLC
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Kala Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Form of Amendment to Offer Letters
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2019
Letter Agreement, dated March 25, 2018, by and between the Registrant and Eric Trachtenberg
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Letter Agreement, dated November 6, 2017, by and between the Registrant and Todd Bazemore
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2018
Amended and Restated Letter Agreement, dated September 10, 2015, by and between the Registrant and Mark Iwicki, as amended by the First Amendment, dated September 28, 2017
Kala Pharmaceuticals, Inc.
Pharmaceuticals
MA
2017
KALA PHARMACEUTICALS, INC. NON-QUALIFIED OPTION AGREEMENT
Kala Pharmaceuticals, Inc.
Pharmaceuticals
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Kala Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017